Thought Leadership Development

Our Clients Make the News

2024

Newsmakers Q&A: BioVectra

How can pharmaceutical and biopharmaceutical companies demonstrate their commitment to ESG principles in manufacturing?

What strategies are being employed to accelerate product development and commercialization without compromising quality?

NEXT-GEN PHARMA: Navigating The AI Revolution In Drug Development and Distribution

Bio/Pharma Outsourcing Innovation eBook February 2024

High-Growth Microbial Fermentation for the Manufacture of Biologics

Proving It’s Clean with Analytics

BioVectra’s Biologic Expansion

Communication is Key in Complex Tech Transfer

PharmTech Bio/Pharma Outsourcing Innovation E-Book

What do you view as the most disruptive or transformational technology or development on the horizon?

Combatting Future Viral Threats with Vaccine Advances

Drug Solutions Podcast: The Future of Vaccine Development

The Flexible Approach to Modern Large & Small Molecule Manufacturing

Video Roundtable: Cell & Gene in a World in Turmoil

eBook: What’s Hot in Outsourcing & Supply Chains?

The Medicine Maker – A Special Series: Supply Chain & Outsourcing

Fall pharma happenings | Pharma Manufacturing

Shining a Light on Junior Pharmaceuticals

BP1122_ezine

Trends Toward Outsourcing Buffer Manufacturing

After M&A sprint, newly unveiled Actylis aims to be ‘much more than just a distributor’: CEO

What is your plan to build a more sustainable business practice in the coming years?

What key indicators do you look at to predict the future of this industry?

Meeting the need for innovative small molecule APIs

Cell and Gene Champions 4

What Goes Wrong When API Quality is Compromised?

BioVectra chief commercial officer has played a pivotal role in firm’s success

Why BioVectra has big mRNA biomanufacturing ambitions

5 MINUTES WITH: Mikael Hagstroem, CEO, LabVantage Solutions

Drug Solutions Podcast: The Evolving Landscape of Oral Solid Dosage Forms

CDMO Roundtable: Managing Orphan Drug Projects

BioVectra: From small molecules to large player

Expansion accelerates across pharma

Digital Lab Transformation in the Energy and Petroleum Sectors

Meeting Demand for Semi-Solid Doses

Supply Chain Considerations for Ensuring Quality

Formulated fill-finish:From curiosity to cure

Drug Digest Video: Pairing the Right APIs and Excipients for Optimizing Formulations

CDMOs – Thinking Through Complexity, James Grabowski, PhD, VP, Portfolio and Sourcing, Curia

CDMOs & Pharma: How are Supply Practices Changing?

< PREVIOUS

NEXT >